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ThObjective: This study aimed to assess extracellular matrix protein expression pat-
terns at the convexity (right anterolateral wall) and the concavity of the dilated
ascending aorta in patients with bicuspid aortic valve disease.
Methods: Aortic wall specimens were retrieved from the convexity and the con-
cavity in 27 bicuspid aortic valve patients (12 with stenosis and 15 with regurgita-
tion) and 6 heart donors (controls). Morphometry, immunohistochemistry, Western
blot, and polymerase chain reaction were performed, focusing on matrix proteins
involved in vascular remodeling.
Results: Type I and III collagens were significantly decreased in bicuspid-associated
dilated aortas versus controls (P  .001), particularly at the convexity (P  .05 vs
concavity). Expression of messenger RNA for collagens was lower than normal only
in the regurgitant subgroup. At immunohistochemistry, proteins whose overproduc-
tion has been demonstrated in response to abnormal wall stress, such as tenascin and
fibronectin, were more expressed in the convexity than in the concavity, especially
in the stenosis subgroup. Tenascin, which is produced by smooth muscle cells in the
synthetic phenotype, was nearly undetectable in controls. Fewer smooth muscle
cells (stenosis, P  .017; regurgitation, P  .008) and more severe elastic fiber
fragmentation (P  .029 and P  .001) were observed in the convexity versus the
concavity.
Conclusions: In bicuspid-associated aortic dilations, an asymmetric pattern of
matrix protein expression was found that was consistent with the asymmetry in
wall-stress distribution reported previously. Differences exist between patients with
stenosis and those with regurgitation in terms of protein expression and content in
the aortic wall. Further studies could clarify the relations between these findings and
the pathogenesis of aortic dilatation in bicuspid aortic valve patients.
The pathogenesis of medial degeneration of the aorta in bicuspid aortic valve(BAV) disease is undefined. Recently, an abnormality in the process ofextracellular matrix (ECM) remodeling (inadequate synthesis, degradation,
and/or transport of ECM proteins) in the aortic wall has been advocated as a possible
mechanism.1,2 The association of aortic wall abnormalities with BAV may derive
from an inherited developmental defect of neural crest cells, which contribute to
both aortic valve and wall embryogenesis,3,4 although a specific responsible gene
has never been identified. Conversely, some authors have argued that the aortic wall
pathology could be mainly secondary to abnormal postvalvular hemodynamics, and
wall-stress overload at the right anterolateral aspect (convexity) has been demon-
strated.5 Flow characteristics are known to influence the morphology and even the
microstructure of the vessel wall.6
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sion of histologic and morphometric features and of ECM
proteins in aneurysmal ascending aortas of patients with BAV.
Among ECM components involved in the processes of tissue
remodeling, collagen, fibronectin, laminin, and tenascin were
object of analysis in this study. Our interest was focused on
type I and III collagen,7 belonging to the class of fibrillar
collagens, and type IV collagen, which is a nonfibrillar type
and participates in basement membrane constitution. Fibronec-
tin in the human aorta is abundantly represented in the basal
lamina–like layers that connect the cells to each other and to
the oxytalan fibers.8 The laminins are glycoproteins localized
in the basal lamina. They regulate cellular differentiation, pro-
liferation, and migration. Among the 5 types of tenascin de-
scribed so far, tenascin C plays crucial roles in embryonic
development and tissue remodeling.9
Methods
Patients and Retrieval Methods
From 2000 to 2003, a total of 143 patients underwent surgery for
ascending aorta or aortic root dilatation at the authors’ institution.
Only patients with a clearly congenital bicuspid valve, as assessed
by both patient history and intraoperative examination and con-
firmed at pathology, were included in the study. The patients
whose aortic valves became bicuspid during their lifetime because
of either rheumatic or degenerative leaflet fusion were excluded, as
were those with atherosclerosis of the ascending aorta, aortitis,
infective endocarditis, and primary connective tissue disorders, eg,
Marfan syndrome. To reduce the heterogeneity of local hemody-
namic conditions, BAV patients with hypertension and those with
mixed valve disease (combined stenosis and regurgitation) were
not included. Thus, 27 patients constituted the study sample, all
with BAV disease and proximal aortic dilatation (Table E1): 12
had aortic valve pure stenosis (mean age, 59 12.1 years), and 15
had isolated aortic valve regurgitation (mean age, 56.3  9.2
years). During the operation, the aortic dilatation appeared asym-
metric in all cases: 2 samples of aortic wall were harvested from
each patient at the aortic convexity (right anterolateral aspect,
above the noncoronary sinus) and concavity (opposite wall), 2 cm
beyond the sinotubular junction. Samples were sectioned into 4
specimens each: 1 was used for histology and morphometry, 1 for
Western blot analysis, and 1 for reverse transcription–polymerase
chain reaction (RT-PCR), and the last specimen was paraffin-
embedded for immunohistochemistry. To be able to define whether
each studied protein was increased or reduced in the diseased
aorta, we chose as a control the normal aorta. Therefore, aortic
wall specimens were retrieved during multiorgan harvesting from
6 normotensive heart donors who had no aneurysmal or athero-
sclerotic disease of the aorta or BAV (mean age, 33  8 years).
Sites of retrieval in control subjects were the same as described
previously. The study was approved by our institution’s ethics
committee.
Echocardiography
Two-dimensional transthoracic and transesophageal echocardiog-
raphy was performed with an Acuson Sequoia C256 machine
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transducer. Aortic valve morphology was evaluated in parasternal
long-axis and short-axis views: a BAV was diagnosed when only
2 cusps were clearly identified in systole and diastole in short-axis
view.
Western Blot
Samples were washed in phosphate-buffered saline (PBS) and then
lysed by lysis buffer (1% Triton X-100 in PBS) containing pro-
tease inhibitors for 30 minutes at 4°C. Lysates were centrifuged at
10,000 rpm for 10 minutes at 4°C; protein concentration was
determined by protein assay (Bio-Rad, Richmond, Colo). For each
sample, the same amount of total proteins was added with Lae-
mmli sample buffer and separated by electrophoresis in 30%
sodium dodecyl sulfate-polyacrylamide gel. Gels were then elec-
troblotted on polyvinylidene difluoride filters (Millipore, Bedford,
Mass); membranes were blocked by 6% fat-free dry milk for 1
hour at room temperature. After 3 washes in washing solution,
membranes were incubated overnight at 4°C with antibodies
against laminin; tenascin; type I, III, and IV collagens (Sigma, St
Louis, Mo); or anti-fibronectin (Chemicon Int, Temecula, Calif).
After washing, membranes were incubated for 45 minutes at room
temperature with horseradish peroxidase–conjugated goat second-
ary antibodies (Bio-Rad). After further washing, membranes were
developed in luminol substrate and exposed to film (ECL for
laminin and fibronectin; ECLplus for tenascin; Amersham Bio-
sciences, Little Chalfont, Buckinghamshire, United Kingdom).
Computer-acquired images were quantified by using ImageQuant
software (Amersham Biosciences).
Reverse Transcription–Polymerase Chain Reaction
RT-PCR was used to analyze target gene expression in this study.
Total RNA was isolated by lysing the frozen aortic vessel tissue
samples (150-300 mg) in Trizol solution (GIBCO BRL, Life
Technologies, Rockville, Md) according to the supplier’s protocol.
RNA was precipitated and quantified by spectroscopy. Two mi-
crograms of total RNA from each sample was reverse-transcribed
by using the First-Strand cDNA Synthesis Kit (Amersham Phar-
macia Biotech, Arlington Heights, Ill) according to the protocol
supplied by the manufacturer. The random hexamer primers pro-
vided in the kit were used. The same complementary DNA product
obtained from each sample was used for subsequent PCR ampli-
fication with the primer sets prepared for the target gene and the
glyceraldehyde phosphate dehydrogenase (GAPDH) housekeeping
gene. See Appendix E1 (online only) for primer sequences. The
amplified products (12 L of each sample) were analyzed by
electrophoresis in a 2% agarose gel containing ethidium bromide,
followed by photography under ultraviolet illumination. The levels
of ECM protein messenger RNA (mRNA) were estimated by
densitometric scanning and normalized against GAPDH loading
controls. Densitometric analyses of the PCR products were per-
formed with ImageJ software version 1.29 (developed by Wayne
Rasband), available online at http://rsb.info.nih.gov/ij/. All PCR
products were purified by using the QIAquick PCR purification kit
(Qiagen, Santa Clarita, Calif), and their identities were verified by
automated DNA forward and reverse sequencing with dideoxy
terminator reaction chemistry for sequence analysis on the Applied
Biosystems (Foster City, Calif) model 373A DNA sequencer.
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Specimens were fixed in buffered 10% formalin, embedded in
paraffin, and sectioned. Serial 4-m-thick sections of aortic spec-
imens were deparaffinized; covered with primary monoclonal an-
tibodies against types I, II, and IV collagen, tenascin, and laminin
or polyclonal antibody for fibronectin (Sigma) and type III colla-
gen (Santa Cruz Biotechnology Inc, Santa Cruz, Calif); and incu-
bated in a moist chamber for 1 hour at 37°C. After some washings
in PBS, they were covered with fluoresceinated secondary anti-
bodies (Sigma) and submitted to the same treatment. Nuclei were
stained with propidium iodide, and then sections were mounted in
Vectashield (Vector Laboratories, Burlingame, Calif) and ob-
served with a Leica DMLB fluorescence microscope (Leica Mi-
crosystems, Inc, Bannockburn, Ill), and a Zeiss LSM510 confocal
microscope (Karl Zeiss International, Jena, Germany). Samples
were evaluated by 3 independent observers by using a 4-point
scale to quantify staining, from none () to greatest ().10
Histology and Morphometry
Specimens were prepared with hematoxylin-eosin, periodic acid–
Schiff, Weigert–van Gieson stain, Alcian–periodic acid–Schiff,
Alcian-Weigert stain for elastic fibers, and von Kossa stain. His-
tologic diagnosis was expressed through the grading system sug-
gested by Schlatmann and Becker11 for medial degeneration. Mor-
phometric analysis was performed by using 2 programs (RM 2100
or RM 5200) of a computer-assisted image-analysis system (VI-
DAS Kontron Elektronik; Zeiss). For each specimen, 10 micro-
scopic fields (620) were randomly selected; the number of elastic
fibers, total smooth muscle cells (SMCs), and normal SMCs alone
(excluding those with signs of cell degeneration) was counted; and
mean values were computed. The length of elastic fibers, consid-
ering their angulation, and their density per field were also
TABLE 1. Western blot results
Variable Normal Regur
Collagen I
Convexity 52.3 2.1 10.
Concavity 51.0 2.0 15.
Collagen III
Convexity 25.8 3.7 15.
Concavity 26.1 2.6 18.
Collagen IV
Convexity 15.1 1.2 25.
Concavity 14.1 2.6 35.
Fibronectin
Convexity 49.8 2.4 52.
Concavity 48.5 2.2 51.
Laminin
Convexity 38.1 0.7† 45.
Concavity 51.8 0.5 50.
All differences (Bonferroni correction) between the amounts of each pr
amounts in controls were significant (P  .001 for collagens; P  .05 for
(concavity: P  .10) and for fibronectin (concavity: P  .09) and laminin (co
*Regurgitant BAV versus stenotic BAV. †P  .05, convexity versus concameasured.
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SPSS software (version 10.1; SPSS Inc, Chicago, Ill) was used for
statistical analysis. Continuous variables were summarized as
mean  standard deviation. Morphometry, Western blot, and PCR
findings were compared between the convexity and the concavity
within each patient group through paired t tests. Differences
among the 3 groups of specimens (control, regurgitant, and ste-
notic) were analyzed by 1-way analysis of variance with Bonfer-
roni correction for post hoc comparisons.
Results
Echocardiography
Echocardiography showed that the mean ascending aortic
diameter was 5.5  1.01 cm in the patients with aortic
regurgitation and 5.7 1.02 cm in those with aortic stenosis
(P  .42). In all study patients, the greatest diameter was
found beyond the sinotubular ridge, at the tubular tract
level. Table E1 shows variables related to valve morphol-
ogy and function. The pattern of cusp fusion was described
at echocardiography and/or reported by the surgeon in the
operative note. Twelve patients had a severe degree of valve
regurgitation and 3 had a moderate degree; among those
with aortic stenosis, it was severe in 10 and moderate in 2.
Western Blot
A significantly decreased amount of type I and type III
collagens was found in dilated aortas compared with con-
trols, and those changes were more evident in specimens
from the convexity of the aorta (Table 1). Type IV collagen
was increased in dilated aortas: in stenotic BAVs, its
t BAV Stenotic BAV P value*
.1† 20.4 1.3† .001
.1 25.6 1.6 .001
.5† 18.6 1.4† .003
.6 24.0 1.5 .001
.4† 46.3 1.6† .001
.8 45.5 2.1 .001
.3 54.0 1.8† .22
.5 44.1 1.2 .001
.8† 33.5 3.2† .001
.1 41.7 4.2 .001
(expressed in nanomoles) in each patient group and the corresponding
in and fibronectin), except for collagen III in stenotic BAV versus normal
ity: P  .40) in regurgitant BAV versus normal. BAV, Bicuspid aortic valve.
paired t test).gitan
7 2
2 2
1 2
1 1
5 1
4 1
5 2
2 4
2 3
3 4
otein
lamin
ncavamount was greater at the convexity (P  .018), and in
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Fibronectin and laminin showed greater variability in di-
lated aortas. On average, patients had more fibronectin at
the convexity than controls (Table 1). The laminin amount
was significantly greater at the concavity than at the con-
vexity in control aortas (P  .001): it appeared increased at
the convexity in regurgitant BAVs, whereas in stenotic
BAVs it was decreased. Tenascin C was not detectable in
normal aortas, whereas its subunits were found in dilated
aortas from BAV patients (Figure 1).
Reverse Transcription–Polymerase Chain Reaction
The mRNA for type I collagen (Figure 2) was reduced in
dilated aortas with regurgitant BAV (P  .03); no signifi-
cant differences were observed between convexity and con-
cavity in all 3 groups. As to the mRNA for type III collagen,
lower levels of expression at the concavity (P  .01 vs
control concavity) were found in regurgitant BAVs (without
a significant difference between the 2 sites of retrieval),
whereas stenotic BAVs showed nearly normal values. Col-
lagen IV mRNA was equally expressed in normal concavity
and convexity, and it was increased in regurgitant (P  .22)
and stenotic (P  .07) BAVs. Figure 2 shows PCR results
for fibronectin and laminin.
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The mean thickness of the aortic wall, when measured in
histologic sections, was 1.82  0.05 mm in concavity and
1.92  0.05 mm in convexity in controls, and it was,
respectively, 1.313  0.06 mm and 1.24  0.04 mm in
dilated aortas with BAV regurgitation and 1.12  0.04 mm
and 0.97  0.06 mm with stenosis. The results of confocal
immunofluorescence are summarized in Table 2.
Histology and Morphometry
At histology, medial degeneration was found in all speci-
mens from patients. The mean degree of medial degenera-
tion in patients with stenosis was 2.7  0.5 in the convexity
versus 1.8  0.6 in the concavity (P  .001); in patients
with regurgitation, it was 2.5  0.5 versus 1.7  0.6,
respectively (P  .001). Morphometry results are displayed
in Table 3. In both the regurgitant and the stenotic BAV
groups, both total and normal SMC numbers were signifi-
cantly reduced in the convexity when compared with the
concavity. More elastic fibers in the convexity than in the
concavity were observed in both groups. This was due to
elastin fragmentation into shorter fibers; this increased their
Figure 1. Tenascin expression evaluated by
Western blot: comparison among controls, di-
lated aortas with regurgitant BAV, and di-
lated aortas with stenotic BAV. Ten, tenascin
subunit (190, 200, and 220 kd); RBAV, regurgi-
tant BAV; SBAV, stenotic BAV; conc, concav-
ity; conv, convexity.counted number but significantly reduced their length.
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between stenotic and regurgitant BAVs, no significant dif-
Figure 2. Messenger RNA amounts for laminin, fibronectin, and
type I collagen as estimated by PCR. Regarding fibronectin, the
great variability between patients observed on Western blot was
also confirmed at PCR, with a tendency toward higher levels at
the convexity in all pathologic aortas. The mRNA for laminin was
always decreased in pathologic samples when compared with
normal ones: in regurgitant BAVs, its expression was signifi-
cantly lower at the convexity than at the concavity (P  .005;
*P < .05 for unpaired t test vs corresponding control specimens;
**P< .05 both vs regurgitant concavity and vs control concavity).
We tried to identify the oligonucleotidic sequence for tenascin C,
but it was not possible to measure its mRNA. Conc, Concavity;
Conv, convexity.ferences emerged.
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In this pilot study, aortic wall changes in patients with BAV
disease were found to be distributed in an asymmetric
fashion and generally had more marked changes at the
convex aspect. This finding could support the hypothesis of
a role of mechanical stress in the development of BAV-
associated dilations, because it is consistent with the evi-
dence in the literature that the blood flow downstream from
a BAV is eccentric, with consequent asymmetric aortic wall
stress and a maximal burden at the convexity.5 Mostly,
biomolecular data consisted with morphologic observations.
The proven overall feasibility of the analysis encourages us
to continue investigating this subject with the same meth-
ods. The criterion of separate analysis of hemodynamic
subgroups (stenosis and regurgitation) was dictated by clin-
ical experience which suggested that BAV patients are a
heterogeneous group.1,12,13 Previous studies, which in-
cluded different clinical phenotypes—such as normally
functioning, stenotic, and regurgitant BAVs, as well as
dilated and nondilated aortas—in the same series, led to
discordant and irreproducible results.14-16
Convexity Versus Concavity
To our knowledge, so far only 1 study2 has included pro-
teins other than fibrillin among the ECM constituents in-
vestigated, but the site of tissue retrieval from the aorta
(convexity or concavity) was not specified. Moreover, that
was an in vitro investigation on cultured cells, and, there-
fore, it may have neglected the complex signal exchange
between cells and matrix,17 as well as the interactions
between medial components and mechanical stimuli that
continuously occur in vivo. In experimental animals,18-20
mechanical factors such as the hypertensive stimulus and
the high flow promoted the SMC change to the synthetic
phenotype, apoptosis, fibronectin and tenascin overexpres-
sion, and release of matrix metalloproteinases. It is interest-
ing to note that in this study, fibronectin and tenascin were
more expressed in the aortic convexity—which is, accord-
ing to previous studies,5,21,22 an area of stress concentration
and flow turbulence—than in the concavity. Fibronectin is
known to promote the modulation from the contractile to the
synthetic phenotype, whereas laminin retains the cells in a
contractile phenotype.17 SMCs in the synthetic state have
been shown to produce tenascin both in vitro and in vivo.23
Tenascin was virtually absent in aortic wall specimens from
healthy subjects in this study, and this is consistent with
previous findings in normotensive animals.18 Conversely,
its presence in specimens from BAV patients suggests SMC
activation and a switch to the synthetic phenotype.
Type I and III collagens, the “scaffold” proteins mainly
localized in fibers associated with the elastic lamellae,8 were
more markedly decreased in the convex than in the concave
aspect of diseased aortas when compared with normal aortas
nd Cardiovascular Surgery ● Volume 130, Number 2 504.e5
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and their asymmetric expression, along with the nonuniform
severity of medial degeneration changes, is consistent with
the common surgical finding of BAV-associated dilatations
that predominantly involve the right anterolateral aspect,
with the typical appearance of asymmetric dilatations,24 as
were observed in this study.
Stenotic Versus Regurgitant BAV
Remarkable differences were observed in ECM compo-
nents between the settings of regurgitant and stenotic
valves. In particular, both type I collagen and its mRNA
were strongly reduced in patients with BAV regurgitation
when compared with healthy patients, whereas in the
stenotic BAV patients, collagen was decreased, but its
mRNA was not different from that of controls (and this
could be considered a sign of a lack of adaptation to
increased stress). Collagen reduction without a propor-
tional reduction in its mRNA, however, suggests that
collagen degradation by proteinases could prevail over
collagen synthesis in the stenosis subgroup. Conversely,
a decrease in the transcription of the protein was more
evident in the regurgitation subgroup. Patients with ste-
TABLE 2. Immunohistochemical examination of the aortic
Variable
Collagen
I III
Normal
Convexity   
Concavity  / 
Regurgitant BAV
Convexity / / 
Concavity / / 
Stenotic BAV
Convexity / / 
Concavity   
In control subjects, the expression and the distribution of extracellular m
tenascin and type IV collagen were virtually absent. Type I and III collag
distribution was found in the stenotic subgroup, with lower positivity in t
stenotic bicuspid aortic valve (BAV) patients, with a greater amount at th
stenotic BAV subgroup, with always a more marked increase at the conve
lightly in regurgitant BAVs at the convexity. Laminin was decreased in st
TABLE 3. Morphometry results (mean number per field)
Variable
Regurgitant BAVs
Convexity Concavity
Total SMCs 274 132.8 590 214.2
Normal SMCs 205 127.3 562 73.9
EF number 949.3 513.9 637.9 333.7
Maximum EF length 11.52 4.7 13.01 2.5
Minimum EF length 0.41 0.1 1.43 0.2BAV, Bicuspid aortic valve; SMCs, smooth muscle cells; EF, elastic fiber. *Con
504.e6 The Journal of Thoracic and Cardiovascular Surgery ● Anotic BAV also had less laminin and more fibronectin and
tenascin than those with regurgitant BAV.
The jet stream through a stenotic valve causes greater
radial stress on the ascending aorta,5,14 whereas the in-
creased stroke volume that occurs with aortic regurgitation
amplifies the ventricular traction on the aortic root that
normally accompanies every heartbeat, thus augmenting
longitudinal rather than radial stress, particularly at the right
anterolateral wall.22 SMCs in the vessel wall could react
differently to different types and degrees of mechanical
stress and could favor, in turn, a predominant production of
either ECM proteins or proteolytic enzymes. Otherwise,
different possible gene defects might concomitantly condi-
tion both the type of dysfunction to which the valve is fated
and the pattern of ECM protein production in the aortic
wall. Aortic dilations associated with BAV stenosis and
those with BAV regurgitation should be probably consid-
ered as different diseases that are possibly amenable to
different therapeutic approaches.
Study Limitations
This study has the limitations of a pilot experience address-
ing such a complex issue as the microstructural changes in
l
Fibronectin Tenascin Laminin
 / /
 / 
  
 / 
  
  /
ECM) proteins were generally uniform between convexity and concavity:
were less expressed in diseased aortas than in controls: an asymmetric
nvexity. Type IV collagen was increased in dilated aortas, particularly in
cavity. Fibronectin was increased in dilated aortas, most evidently in the
Immunostaining for tenascin was more evident in stenotic BAVs and only
BAV concavity, whereas in regurgitant BAVs it was similar to controls.
Stenotic BAVs
value* Convexity Concavity P value*
.001 356.7 36.9 622.3 180.6 .014
.008 207 165.1 437 73.9 .017
.165 937.5 188.4 616.4 260.8 .002
.232 10.57 4.1 13.62 1.9 .032
.001 0.22 0.2 1.46 0.6 .029wal
IV
/
/



atrix (
ens
he co
e con
xity.Pcavity versus convexity.
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raised are perhaps more numerous than the answers pro-
vided. The asymmetric pattern of medial changes qualita-
tively and quantitatively coincides with the already-known
wall-stress asymmetry in BAV disease; however, at this
point, no clear causal mechanism can be demonstrated.
Matching each patient’s morphostructural data with the
respective measurements of flow and stress characteristics
(eg, through computed tomographic scan–derived patient-
specific finite element models) will probably allow for a
more direct and detailed description of the relations between
wall stress and ECM changes. Finally, the normal setting
Figure 3. Immunopositivity for type I collagen (in green; confocal
microscopy) in the aortic wall (the intimal layer is above) in a
patient with stenotic BAV. A, Healthy subject, concavity. B,
Healthy subject, convexity. C, Regurgitant BAV, convexity. D,
regurgitant BAV, concavity.(healthy valve, nondilated aorta) was chosen as the control
The Journal of Thoracic agroup to recognize changes in patients. This was necessary
for this first experience; however, further considerations
could derive from comparing dilatations associated with
BAV stenosis and regurgitation with those associated with
tricuspid aortic valve stenosis and regurgitation of the same
degree.
Conclusions
In conclusion, the novel finding of an asymmetric pattern of
medial degeneration lesion distribution in BAV-associated
aortic dilatations argues in favor of a possible central role of
uneven wall stress in the pathogenesis of aortic dilatation.
Among ECM proteins, fibronectin and tenascin were in-
creased in the wall area of expected greater stress, whereas
this relation was inverse for collagens I and III. Whether
abnormal stress is the main causative factor or just interacts
with an underlying genetic defect that might alter tissue
adaptation to stress is still to be elucidated. Differences exist
between patients with BAV stenosis and those with BAV
regurgitation in terms of protein expression and content in
the aneurysmal aortic wall; therefore, separate analysis of
hemodynamic subgroups is advisable when this topic is
addressed.
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Cotrufo et al Surgery for Acquired Cardiovascular DiseaseTABLE E1. Demographics, aortic valve features, and aortic diameter in BAV patients
Patient No. Age (y) Sex BSA (m2) BAV disease Degree Ascending aorta (cm) Cusp fusion pattern
1 48 M 2.00 Regurgitation 4 5.0 Left/right
2 44 M 2.20 Regurgitation 4 6.5 Left/right
3 60 F 1.52 Regurgitation 4 4.5 Right/noncoronary
4 57 M 1.70 Regurgitation 3 5.0 Left/right
5 65 M 2.20 Regurgitation 4 6.0 Not available*
6 66 M 1.67 Regurgitation 4 4.8 Right/noncoronary
7 49 M 1.83 Regurgitation 4 5.1 Left/right
8 50 F 1.84 Regurgitation 4 4.9 Left/right
9 63 M 1.82 Regurgitation 4 5.0 Right/noncoronary
10 70 F 1.82 Regurgitation 3 8.3 Left/right
11 61 M 1.73 Regurgitation 4 6.2 Not available*
12 67 M 1.66 Regurgitation 4 4.9 Right/noncoronary
13 47 M 1.60 Regurgitation 4 4.7 Left/right
14 41 M 1.94 Regurgitation 4 6.4 Not available*
15 56 F 2.10 Regurgitation 3 5.8 Left/right
16 47 M 1.84 Stenosis 4 5.5 Left/right
17 74 F 1.83 Stenosis 4 4.6 Right/noncoronary
18 60 M 1.82 Stenosis 4 4.7 Right/noncoronary
19 75 M 1.71 Stenosis 4 5.0 Not available*
20 45 F 1.74 Stenosis 3 6.2 Left/right
21 71 M 1.70 Stenosis 4 4.5 Right/noncoronary
22 55 F 1.90 Stenosis 4 5.7 Left/right
23 58 F 1.81 Stenosis 4 6.0 Not available*
24 74 M 1.84 Stenosis 4 5.4 Right/noncoronary
25 55 F 1.77 Stenosis 3 6.5 Left/right
26 47 M 1.86 Stenosis 4 7.4 Right/noncoronary
27 43 M 1.96 Stenosis 4 7.5 Not available*
BAV, Bicuspid aortic valve; BSA, body surface area. *Unidentified at echocardiography and not reported in the operative note.
APPENDIX E1. Oligonucleotide sequences used for RT-PCR
Target mRNA Primer Sequence PCR product (bp)
GAPDH Forward 5=-GAGTCAACGGATTTGGTC-3= 238
Reverse 5=-TTGATTTTGGAGGGATCT-3=
Fibronectin Forward 5=-CCCAACTGGCATTGACTTTT-3= 136
Reverse 5=-CTCGAGGTCTTTCACTGAAG-3=
Laminin 2 Forward 5=-AAAGTATCTGTGTCTTCAGGAGGTGC-3= 474
Reverse 5=-GCAGCCAGTGAATGTAATCACACGTC-3=
Collagen I 1 Forward 5=-CTCCCCAGAAGACACAGGAA-3= 203
Reverse 5=-TCAAAAACGAAGGGGAGATG-3=
Collagen III 1 Forward 5=-TACGGCAATCCTGAACTT-3= 245
Reverse 5=-GTGTGTTTCGTGCAACCA-3=
Collagen IV 2 Forward 5=-CCAAGGAAGAGGTGGTGT-3= 169
Reverse 5=-GTGCTTCACCAGGAGGTA-3=
Tenascin C Forward 5=-TCAAGGCTGCTACGCCTTAT-3= 230
Reverse 5=-GTTCTGGGCTGCCTCTACTG-3=
Primer sequences were designed by using the software Primer 3 (developed by Steve Rozen and Helen J. Skaletsky), which is available online at
http://www-genome.wi.mit.edu. The optimal annealing temperature for all the primer pairs was 55°C. The amplification of the GAPDH gene was used as
a double internal control. The ratio between the samples and the housekeeping gene was calculated to normalize for initial variations in sample
concentration and as a control for reaction efficiency. RT-PCR, Reverse transcription–polymerase chain reaction; mRNA, messenger RNA; GAPDH,
glyceraldehyde phosphate dehydrogenase; bp, base pairs.
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